3.40 % to Target, Jefferies & Co Keeps ‘”Hold”’ Rating on CVS Health Corporation (NYSE:CVS) Shares Today

September 17, 2017 - By Adrian Erickson

 3.40 % to Target, Jefferies & Co Keeps ‘

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It worsened, as 135 investors sold CVS Health Corp shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported.

Mcdaniel Terry accumulated 2.32% or 141,568 shares. 14,202 were reported by Eads Heald Investment Counsel. Moreover, Delphi Management Inc Ma has 1.12% invested in CVS Health Corp (NYSE:CVS) for 24,241 shares. U S Investors Inc holds 6,825 shares. Department Mb Natl Bank N A reported 1.08% stake. Scotia Inc stated it has 478,547 shares or 0.6% of all its holdings. The Iowa-based Principal Group has invested 0.34% in CVS Health Corp (NYSE:CVS). Veritable Limited Partnership invested in 39,779 shares. 266,630 are held by Toronto Dominion Bank & Trust. Royal Fincl Bank Of Canada stated it has 5.00 million shares or 0.21% of all its holdings. Argyle Mngmt Inc has 16,225 shares. Rothschild Asset Mgmt reported 11,032 shares. Davidson And Garrard Inc holds 2.05% or 104,756 shares in its portfolio. 4,612 are owned by Bangor Bank & Trust. Moreover, Metropolitan Life Ins New York has 0.33% invested in CVS Health Corp (NYSE:CVS).

Since March 17, 2017, it had 0 insider buys, and 1 insider sale for $18.44 million activity. Boratto Eva C also sold $479,908 worth of CVS Health Corp (NYSE:CVS) on Friday, March 17. $1.88 million worth of stock was sold by Brennan Troyen A on Tuesday, March 21.

CVS Health Corporation (NYSE:CVS) Rating Reaffirmed

They currently have a $86.00 target price on CVS Health Corporation (NYSE:CVS). The target price by Jefferies & Co would suggest a potential upside of 3.40 % from the company’s current price. This has been shown in an analyst note on Friday, 15 September.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It worsened, as 135 investors sold CVS Health Corp shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported.

Mcdaniel Terry accumulated 2.32% or 141,568 shares. 14,202 were reported by Eads Heald Investment Counsel. Moreover, Delphi Management Inc Ma has 1.12% invested in CVS Health Corp (NYSE:CVS) for 24,241 shares. U S Investors Inc holds 6,825 shares. Department Mb Natl Bank N A reported 1.08% stake. Scotia Inc stated it has 478,547 shares or 0.6% of all its holdings. The Iowa-based Principal Group has invested 0.34% in CVS Health Corp (NYSE:CVS). Veritable Limited Partnership invested in 39,779 shares. 266,630 are held by Toronto Dominion Bank & Trust. Royal Fincl Bank Of Canada stated it has 5.00 million shares or 0.21% of all its holdings. Argyle Mngmt Inc has 16,225 shares. Rothschild Asset Mgmt reported 11,032 shares. Davidson And Garrard Inc holds 2.05% or 104,756 shares in its portfolio. 4,612 are owned by Bangor Bank & Trust. Moreover, Metropolitan Life Ins New York has 0.33% invested in CVS Health Corp (NYSE:CVS).

Since March 17, 2017, it had 0 insider buys, and 1 insider sale for $18.44 million activity. Boratto Eva C also sold $479,908 worth of CVS Health Corp (NYSE:CVS) on Friday, March 17. $1.88 million worth of stock was sold by Brennan Troyen A on Tuesday, March 21.

CVS Health Corp (NYSE:CVS) Ratings Coverage

Among 23 analysts covering CVS Health (NYSE:CVS), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. CVS Health has $132 highest and $77 lowest target. $103.44’s average target is 24.37% above currents $83.17 stock price. CVS Health had 39 analyst reports since July 22, 2015 according to SRatingsIntel. Argus Research maintained CVS Health Corp (NYSE:CVS) rating on Monday, August 10. Argus Research has “Buy” rating and $118.0 target. The firm has “Buy” rating given on Friday, April 28 by Tigress Financial. The company was maintained on Tuesday, June 13 by Cowen & Co. Wolfe Research downgraded the stock to “Hold” rating in Wednesday, August 16 report. Citigroup maintained CVS Health Corp (NYSE:CVS) rating on Monday, May 9. Citigroup has “Neutral” rating and $115 target. The firm has “Hold” rating given on Friday, September 8 by Needham. On Monday, June 20 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. Robert W. Baird initiated the stock with “Outperform” rating in Friday, January 22 report. Oppenheimer maintained it with “Outperform” rating and $119.0 target in Friday, August 28 report. S&P Research maintained CVS Health Corp (NYSE:CVS) on Monday, November 2 with “Strong Buy” rating.

The stock increased 0.64% or $0.53 on September 15, reaching $83.17. About 7.48M shares traded or 46.09% up from the average. CVS Health Corp (NYSE:CVS) has declined 24.40% since September 17, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors wait CVS Health Corp (NYSE:CVS) to report on November, 14. its quarterly earnings Wall Street analysts expect $1.49 earnings per share, down $0.15 or 9.15 % from last year’s $1.64 same quarter earnings. This translates into $1.51B profit for CVS giving the stock a 13.95 P/E. This is assuming the current $1.49 EPS is accurate. CVS Health Corp’s Wall Street analysts see 12.03 % EPS growth, taking into account the $1.33 EPS reproted in the previous quarter,

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The company has market cap of $84.55 billion. The Firm provides pharmacy care for the senior community through Omnicare, Inc. and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It has a 16.57 P/E ratio. It operates through three divisions: Pharmacy Services, Retail/LTC and Corporate.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Seekingalpha.com which released: “This Bottoming Healthcare Stock Just Narrowed Its Guidance” on August 18, 2017, also Fool.com with their article: “CVS Health Hopes Partnerships Will Power Growth” published on August 22, 2017, Bizjournals.com published: “CVS Health hiring 200 in Pittsburgh” on September 08, 2017. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Seekingalpha.com and their article: “CareFirst BCBS re-ups with CVS Caremark” published on September 05, 2017 as well as Nasdaq.com‘s news article titled: “Rikoon Group, LLC Buys SPDR S&P Dividend, CVS Health Corp, Accenture PLC …” with publication date: August 18, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.